{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:04:37Z","timestamp":1793117077141,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Centers for Disease Control and Prevention","award":["Contract 200-2012-53526"],"award-info":[{"award-number":["Contract 200-2012-53526"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the association between antenatal messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination and risk of adverse pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This was a retrospective cohort study of individuals with singleton pregnancies with live deliveries between June 1, 2021, and January 31, 2022, with data available from eight integrated health care systems in the Vaccine Safety Datalink.\n                      <jats:italic toggle=\"yes\">Vaccine exposure<\/jats:italic>\n                      was defined as receipt of one or two mRNA COVID-19 vaccine doses (primary series) during pregnancy. Outcomes were preterm birth (PTB) before 37 weeks of gestation, small-for-gestational age (SGA) neonates, gestational diabetes mellitus (GDM), gestational hypertension, and preeclampsia\u2013eclampsia\u2013HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Outcomes in individuals vaccinated were compared with those in propensity-matched individuals with unexposed pregnancies. Adjusted hazard ratios (aHRs) and 95% CIs were estimated for PTB and SGA using a time-dependent covariate Cox model, and adjusted relative risks (aRRs) were estimated for GDM, gestational hypertension, and preeclampsia\u2013eclampsia\u2013HELLP syndrome using Poisson regression with robust variance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Among 55,591 individuals eligible for inclusion, 23,517 (42.3%) received one or two mRNA COVID-19 vaccine doses during pregnancy. Receipt of mRNA COVID-19 vaccination varied by maternal age, race, Hispanic ethnicity, and history of COVID-19. Compared with no vaccination, mRNA COVID-19 vaccination was associated with a decreased risk of PTB (rate: 6.4 [vaccinated] vs 7.7 [unvaccinated] per 100, aHR 0.89; 95% CI, 0.83\u20130.94). Messenger RNA COVID-19 vaccination was not associated with SGA (8.3 vs 7.4 per 100; aHR 1.06, 95% CI, 0.99\u20131.13), GDM (11.9 vs 10.6 per 100; aRR 1.00, 95% CI, 0.90\u20131.10), gestational hypertension (10.8 vs 9.9 per 100; aRR 1.08, 95% CI, 0.96\u20131.22), or preeclampsia\u2013eclampsia\u2013HELLP syndrome (8.9 vs 8.4 per 100; aRR 1.10, 95% CI, 0.97\u20131.24).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Receipt of an mRNA COVID-19 vaccine during pregnancy was not associated with an increased risk of adverse pregnancy outcomes; this information will be helpful for patients and clinicians when considering COVID-19 vaccination in pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005583","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T17:04:49Z","timestamp":1713287089000},"page":"794-802","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination"],"prefix":"10.1097","volume":"143","author":[{"given":"Kimberly K.","family":"Vesco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Denoble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather S.","family":"Lipkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse O.","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini B.","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew F.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darios","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousseny","family":"Zerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace C.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Vazquez-Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.2022.1190","article-title":"Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications","volume":"327","author":"Metz","year":"2022","journal-title":"JAMA"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","article-title":"Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19)","volume":"137","author":"Metz","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"522 e1","DOI":"10.1016\/j.ajog.2021.05.016","article-title":"Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study","volume":"225","author":"Gurol-Urganci","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"e2233273","DOI":"10.1001\/jamanetworkopen.2022.33273","article-title":"Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of delta and omicron variant predominance in the United States","volume":"5","author":"Schrag","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41467-023-36547-4","article-title":"Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life","volume":"14","author":"Zerbo","year":"2023","journal-title":"Nat Commun"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"236.e1","DOI":"10.1016\/j.ajog.2021.08.007","article-title":"COVID-19 vaccination during pregnancy: coverage and safety","volume":"226","author":"Blakeway","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/s41467-022-30052-w","article-title":"Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy","volume":"13","author":"Prasad","year":"2022","journal-title":"Nat Commun"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R11-20260916","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"20420986211021233","DOI":"10.1177\/20420986211021233","article-title":"Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination","volume":"12","author":"Naleway","year":"2021","journal-title":"Ther Adv Drug Saf"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.vaccine.2021.02.070","article-title":"Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy","volume":"39","author":"Fell","year":"2021","journal-title":"Vaccine"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/kww043","article-title":"Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: Caveats when conducting retrospective observational studies","volume":"184","author":"Vazquez-Benitez","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.vaccine.2021.12.048","article-title":"Monitoring vaccine safety using the Vaccine Safety Datalink: assessing capacity to integrate data from Immunization Information systems","volume":"40","author":"Groom","year":"2022","journal-title":"Vaccine"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"e2314350","DOI":"10.1001\/jamanetworkopen.2023.14350","article-title":"COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion","volume":"6","author":"Kharbanda","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1542\/peds.2013-3285","article-title":"United States birth weight reference corrected for implausible gestational age estimates","volume":"133","author":"Talge","year":"2014","journal-title":"Pediatrics"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/EDE.0000000000001311","article-title":"Validation of ICD-10 codes for gestational and pregestational diabetes during pregnancy in a large, public hospital","volume":"32","author":"Stanhope","year":"2021","journal-title":"Epidemiology"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2105\/AJPH.84.9.1414","article-title":"An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed adequacy of prenatal care utilization index","volume":"84","author":"Kotelchuck","year":"1994","journal-title":"Am J Public Health"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. American College of Obstetricians and Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15585\/mmwr.mm7101e1","article-title":"Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth\u2014Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021","volume":"71","author":"Lipkind","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(22)02467-9","article-title":"Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study","volume":"401","author":"Villar","year":"2023","journal-title":"Lancet"},{"key":"R25-20260916","first-page":"e14125","article-title":"COVID-19 vaccine and hyperosmolar hyperglycemic state","volume":"13","author":"Abu-Rumaileh","year":"2021","journal-title":"Cureus"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"e14631","DOI":"10.1111\/dme.14631","article-title":"Acute hyperglycaemic crisis after vaccination against COVID-19: a case series","volume":"38","author":"Edwards","year":"2021","journal-title":"Diabet Med"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"bvab141","DOI":"10.1210\/jendso\/bvab141","article-title":"Hyperglycemic emergencies associated with COVID-19 vaccination: a case series and discussion","volume":"5","author":"Lee","year":"2021","journal-title":"J Endocr Soc"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"e2255965","DOI":"10.1001\/jamanetworkopen.2022.55965","article-title":"Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection","volume":"6","author":"Kwan","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:02:35Z","timestamp":1789556555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005583","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"2024-01-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}